← Back to Vaccine Database

Human Adenovirus Type 5

Viral vector (Non-replicating) vaccine · VDDBV0411

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (Non-replicating) vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials6

NCT IDPhaseDisease / Condition
NCT04591717 Phase 1COVID-19
NCT04710303 Phase 1COVID-19
NCT04732468 Phase 1COVID-19
NCT04843722 Phase 2COVID-19
NCT04845191 Phase 2COVID-19
NCT04843722 Phase 2COVID-19